Home / Health / 13 Years on Dialysis, Now a New Life with Wonder Drug
13 Years on Dialysis, Now a New Life with Wonder Drug
28 Jan
Summary
- A new drug, Imlifidase, prevents organ rejection after kidney transplants.
- Lorraine received a successful kidney transplant after 13 years on dialysis.
- The drug is now available on the NHS and has been used 8 times in the UK.
A revolutionary new drug, Imlifidase, is offering new hope for kidney transplant patients. This medication has successfully prevented organ rejection, enabling successful transplants for individuals who previously faced prolonged periods on dialysis.
Lorraine is one such patient whose life has been profoundly changed by Imlifidase. After 13 years dependent on dialysis, her body accepted a new kidney without rejection, marking a pivotal moment in her medical journey. This drug, now accessible through the NHS, has been utilized eight times across the UK.
Glenfield Hospital in Leicester has been at the forefront of administering this innovative treatment, performing two of the eight successful transplant procedures. The availability of Imlifidase represents a significant advancement in transplant medicine, offering a brighter future for many.
